PMFA
PGNX

Plante Moran Financial Advisors’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Plante Moran Financial Advisors’s Portfolio PGNX Stock Details PGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-152
Closed -$1K – 1094
2015
Q4 		$1K Buy
+152
New +$996 ﹤0.01% 930

Other funds holding PGNX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Plante Moran Financial Advisors's PGNX Position: Q1 2016 in Review

Plante Moran Financial Advisors sold out of Progenics Pharmaceuticals Inc (PGNX) in Q1 2016, closing a stake of 152 shares — an estimated $1K sold.

Plante Moran Financial Advisors first reported a position in PGNX in Q4 2015 and held it in 1 quarter. The position peaked at $1K in Q4 2015. 120 funds tracked by Wall St. Rank hold PGNX as of Q1 2016.

  • Plante Moran Financial Advisors reported no remaining Progenics Pharmaceuticals Inc position as of Q1 2016 after selling out during the quarter.
  • Plante Moran Financial Advisors sold 152 Progenics Pharmaceuticals Inc shares in Q1 2016, an estimated $1K.
  • Plante Moran Financial Advisors first reported a position in Progenics Pharmaceuticals Inc in Q4 2015 and held it in 1 quarter.
  • Plante Moran Financial Advisors's Progenics Pharmaceuticals Inc position peaked at $1K in Q4 2015.
  • 120 funds tracked by Wall St. Rank held Progenics Pharmaceuticals Inc as of Q1 2016.

Based on Plante Moran Financial Advisors's 13F filing for Q1 2016, filed 26 Apr 2016.